Imaging
19 COMMENTS - Oct 30, 2009 16:00 EDT
Just weeks before ARBITER-HALTS 6 results come out at AHA 2009, an MRI study suggests that niacin is better than placebo in statin-treated patients with low HDL, at least for reducing carotid wall area. Experts say they'd also like to see insights into niacin effects on lipid-rich plaque volumes—the more commonly seen end point with MRI.

Oxford, UK - A new imaging study is providing a first hint at the potential for niacin to help with plaque regression when used on top of optimized statin therapy [1]. Writing in the November 3, 2009 issue of the Journal of the American College of Cardiology (JACC), Dr Justin MS Lee (University of Oxford, UK) and colleagues report that 2 g of modified-release nicotinic acid (Niaspan, Abbott Laboratories) daily, on top of statins, resulted in a 1.64 mm2 reduction in carotid wall area on MRI, compared with placebo, in patients with vascular disease and low HDL. Read full article »

Inside: Imaging
Accredited educational programs, supported by industry, developed by theheart.org

 
heartbriefs
Nov 20, 2009 13:15 EST
As part of his mission to see more financial transparency in medicine, Sen Grassley has asked eight top US medical schools about their policies on ghostwriting.
News
Nov 19, 2009 10:00 EST
Publicly released report cards based on hospital performance did not result in a measurably greater systemwide improvement in two composite AMI or CHF process-of-care indicators in a Canadian study. But they did appear to stimulate some important changes in delivery of care that could have led to some better outcomes.
Imaging
4 COMMENTS - Nov 18, 2009 13:45 EST
The use of coronary CT angiography in the emergency room can successfully triage at-risk chest-pain patients and can do so faster and less expensively than standard diagnostic testing.
Interventional/Surgery
Nov 15, 2009 10:30 EST
Inflation of the paclitaxel-delivering balloon followed by a bare-metal stent failed a randomized noninferiority test against the Cypher sirolimus-eluting stent in previously untreated coronary lesions.
Prevention
8 COMMENTS - Nov 15, 2009 09:00 EST
Family doctors and general practitioners in Canada are confused about cardiovascular risk assessment in primary prevention, a new survey reveals.
Medscape Medical News
Nov 12, 2009 15:00 EST
Now that the US House of Representatives has passed a healthcare reform bill, organized medicine anticipates another vote—possibly next week—on a second bill that would rewrite Medicare's controversial sustainable-growth-rate formula for physician reimbursement.
Interventional/Surgery
4 COMMENTS - Nov 12, 2009 13:15 EST
A new postmortem study using high-resolution imaging has found that fractures in drug-eluting stents may be more common than thought. However, the majority of such fractures appear to be low-grade and silent, with likely few clinical implications, say the researchers.
News
2 COMMENTS - Nov 11, 2009 09:00 EST
Anticipation is building for full trial results from ARBITER 6-HALTS, plus a better understanding of what went wrong with cangrelor in the CHAMPION trials. Also in the lineup are updates from PLATO, RE-LY, ALLHAT, BARI 2D, STICH, CASCADE, POPULAR, HEARTMATE II, and many more. Indeed, this year's "late-breaking" sessions include more than 30 trials over five days.
heartbriefs
Nov 9, 2009 17:00 EST
Coronary plaque burden in patients with acute chest pain increases significantly over two years. A new Harvard study evaluates CTA as a tool to follow the progression.
Arrhythmia/EP
Nov 9, 2009 17:00 EST
Obesity and hypertension were major independent risk factors for left atrial enlargement (itself a risk factor for atrial fibrillation) in an observational, population-based study, but obesity was the strongest predictor.
Imaging
Nov 9, 2009 16:00 EST
Distinguishing myocardial scarring with MRI may help predict LV functional recovery.
Editorial Programs
The Cardiology Show
1 COMMENT - Nov 18, 2009 16:30 EST
Join Drs Valentin Fuster, Roger Blumenthal, Bob Harrington, Judith Hochman, Sanjay Kaul, Suzanne Oparil, Gregg Stone, Lynne Warner Stevenson, and Bruce Wilkoff as they discuss the results of ARBITER 6-HALTS, the PLATO STEMI subanalysis, the two CHAMPIONs, and CASCADE and tackle the issue of too little, too soon in clinical trials today.
Editorial series
Nov 11, 2009 09:50 EST
New agents and interventions are paving the way for revised modalities in the management of patients with atrial fibrillation. Join Drs Alpert and Delascio Lopes for a review of the latest findings and options.
Editorial series
Oct 30, 2009 12:35 EDT
How do regulatory pathways differ in the US and UK? Drs Harrington, Bhatt, and Cleland share their experiences and offer insight on how to support innovative research.
Radio: The Bob Harrington Show
Jan 9, 2008 16:31 EST
button
Previews
Info from Industry
Analyze this image
Imaging
Oct 21, 2009 09:16 EDT
Analyze This Image
Sep 25, 2009 09:35 EDT
Case studies
Case studies
Nov 4, 2009 09:16 EST
Join Dr Viles-Gonzalez as he explains the cause of mitral regurgitation in a 66 year-old male patient.
Case studies
Oct 2, 2009 12:15 EDT
Join Dr Viles-Gonzalez as he examines the case of a 44 year old man with dyspnea on exertion.